T1	Participants 370 372	We
T2	Participants 448 456	patients
T3	Participants 575 596	colon cancer patients
T4	Participants 962 983	BRAF-mutated patients
T5	Participants 930 958	431 BRAF wild-type patients,
T6	Participants 1396 1414	patients with BRAF
T7	Participants 1562 1580	patients with BRAF
